CLASS I Drug recall · Reported 7 May 2014 · FDA Enforcement Report

Ceftriaxone for Injection and Dextrose Injection in Duplex Container recalled

B. Braun Medical is recalling Ceftriaxone for Injection and Dextrose Injection in Duplex Container, distributed nationwide in the US. The recall was initiated on 21 Nov 2013 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot# H3B702, Exp 02/15
Quantity recalled32,376 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1266-2014
FDA event ID
66913
Recalling firm
B. Braun Medical, Irvine, CA
Classification
Class I
Status
Terminated
Recall initiated
21 Nov 2013
FDA classified
25 Apr 2014
Reported
7 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter
Drug class
Antibiotics

Timeline

21 Nov 2013Recall initiated by company
25 Apr 2014Classified by FDA+155 days
7 May 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Product as listed by the FDA

Ceftriaxone for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog Number 3153-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895

Where it was distributed

Nationwide, Puerto Rico and Spain

Nationwide Puerto Rico

Questions about this recall

Is Ceftriaxone for Injection and Dextrose Injection in Duplex Container recalled?

Yes. B. Braun Medical recalled Ceftriaxone for Injection and Dextrose Injection in Duplex Container on 21 Nov 2013. The recall is Class I and its status is Terminated. Recall number D-1266-2014.

Why was it recalled?

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Which lots are affected?

Lot# H3B702, Exp 02/15

Where was it sold?

Nationwide, Puerto Rico and Spain

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from B. Braun Medical

All 447

Other Ceftriaxone recalls

All 21